Radcliffe Capital Management’s EUDA Health Holdings Warrant EUDAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-12,345
Closed -$124K – 889
2022
Q3
$124K Sell
12,345
-37,655
-75% -$12.2K ﹤0.01% 1169
2022
Q2
$494K Buy
+50,000
New +$14.2K 0.01% 1128

Other funds holding EUDAW

Radcliffe Capital Management's EUDAW Position: Q4 2022 in Review

Radcliffe Capital Management sold out of EUDA Health Holdings Warrant (EUDAW) in Q4 2022, closing a stake of 12,345 shares — an estimated $124K sold.

Radcliffe Capital Management first reported a position in EUDAW in Q2 2022 and held it in 2 quarters. The position peaked at $494K in Q2 2022. 13 funds tracked by Wall St. Rank hold EUDAW as of Q4 2022.

  • Radcliffe Capital Management reported no remaining EUDA Health Holdings Warrant position as of Q4 2022 after selling out during the quarter.
  • Radcliffe Capital Management sold 12,345 EUDA Health Holdings Warrant shares in Q4 2022, an estimated $124K.
  • Radcliffe Capital Management first reported a position in EUDA Health Holdings Warrant in Q2 2022 and held it in 2 quarters.
  • Radcliffe Capital Management's EUDA Health Holdings Warrant position peaked at $494K in Q2 2022.
  • 13 funds tracked by Wall St. Rank held EUDA Health Holdings Warrant as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.